Project in collaboration with the Nemours Children's Hospital under Dr. Erin L. Crowgey (now at Incyte) and Prof. Adam Marsh, leveraging machine learning approaches to predict outcomes for rare diseases using transcriptomics, variant data, and electronic health records.